iohexol has been researched along with Adverse Drug Event in 11 studies
Iohexol: An effective non-ionic, water-soluble contrast agent which is used in myelography, arthrography, nephroangiography, arteriography, and other radiographic procedures. Its low systemic toxicity is the combined result of low chemotoxicity and low osmolality.
iohexol : A benzenedicarboxamide compound having N-(2,3-dihydroxypropyl)carbamoyl groups at the 1- and 3-positions, iodo substituents at the 2-, 4- and 6-positions and an N-(2,3-dihydroxypropyl)acetamido group at the 5-position.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Iopromide was shown to be a well-tolerated contrast agent whose usage resulted in high image quality." | 1.38 | Safety and diagnostic image quality of iopromide: results of a large non-interventional observational study of European and Asian patients (IMAGE). ( Heinsohn, C; Kwon, ST; Lengsfeld, P; Liang, CH; Palkowitsch, P; Stauch, K; Zhang, SX, 2012) |
| "5 million adverse drug reaction (ADR) reports for 8620 drugs/biologics that are listed for 1191 Coding Symbols for Thesaurus of Adverse Reaction (COSTAR) terms of adverse effects." | 1.32 | Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling. ( Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (18.18) | 29.6817 |
| 2010's | 8 (72.73) | 24.3611 |
| 2020's | 1 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Matthews, EJ | 1 |
| Kruhlak, NL | 1 |
| Weaver, JL | 1 |
| Benz, RD | 1 |
| Contrera, JF | 1 |
| Liu, Z | 1 |
| Shi, Q | 1 |
| Ding, D | 1 |
| Kelly, R | 1 |
| Fang, H | 1 |
| Tong, W | 1 |
| Morgan, RE | 1 |
| van Staden, CJ | 1 |
| Chen, Y | 1 |
| Kalyanaraman, N | 1 |
| Kalanzi, J | 1 |
| Dunn, RT | 1 |
| Afshari, CA | 1 |
| Hamadeh, HK | 1 |
| Kim, SR | 1 |
| Son, NH | 1 |
| Park, HJ | 1 |
| Park, KH | 1 |
| Park, JW | 1 |
| Lee, JH | 1 |
| Murakami, R | 1 |
| Kumita, S | 1 |
| Hayashi, H | 1 |
| Sugizaki, K | 1 |
| Okazaki, E | 1 |
| Kiriyama, T | 1 |
| Hakozaki, K | 1 |
| Tani, H | 1 |
| Miki, I | 1 |
| Takeda, M | 1 |
| Kalaiselvan, V | 1 |
| Sharma, S | 1 |
| Singh, GN | 1 |
| Li, X | 2 |
| Chen, J | 1 |
| Zhang, L | 1 |
| Liu, H | 1 |
| Wang, S | 2 |
| Chen, X | 1 |
| Fang, J | 1 |
| Zhang, W | 1 |
| Chen, JY | 1 |
| Liu, Y | 1 |
| Zhou, YL | 1 |
| Tan, N | 1 |
| Zhang, B | 2 |
| Chen, PY | 1 |
| Chen, LB | 1 |
| Dong, Y | 1 |
| Liang, L | 1 |
| Lian, Z | 1 |
| Liu, J | 1 |
| Luo, X | 1 |
| Chen, W | 1 |
| Liang, C | 1 |
| Zhang, S | 1 |
| Palkowitsch, P | 1 |
| Lengsfeld, P | 1 |
| Stauch, K | 1 |
| Heinsohn, C | 1 |
| Kwon, ST | 1 |
| Zhang, SX | 1 |
| Liang, CH | 1 |
| Gul, KM | 1 |
| Mao, SS | 1 |
| Gao, Y | 1 |
| Oudiz, RJ | 1 |
| Rasouli, ML | 1 |
| Gopal, A | 1 |
| Budoff, MJ | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Safety Profile of Ultravist in Patients With Different Sexes, Races and From Different Countries/Regions[NCT05428397] | 152,233 participants (Actual) | Observational | 2022-06-30 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for iohexol and Adverse Drug Event
| Article | Year |
|---|---|
Noninvasive gadolinium-enhanced three dimensional computed tomography coronary angiography.
Topics: Adult; Aged; Aged, 80 and over; Contrast Media; Coronary Angiography; Coronary Artery Disease; Dose- | 2006 |
10 other studies available for iohexol and Adverse Drug Event
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Dru | 2004 |
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
Topics: Animals; Anti-Infective Agents; Anti-Inflammatory Agents; Chemical and Drug Induced Liver Injury; Da | 2011 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily | 2013 |
Differences in the Recurrence Rate of Immediate Adverse Drug Reactions According to the Components of Alternative Contrast Media: Analysis of Repetitive Computed Tomography Cases in a Single Tertiary Hospital.
Topics: Contrast Media; Drug-Related Side Effects and Adverse Reactions; Humans; Iohexol; Iopamidol; Retrosp | 2022 |
Anemia and the risk of contrast-induced nephropathy in patients with renal insufficiency undergoing contrast-enhanced MDCT.
Topics: Acute Kidney Injury; Aged; Anemia; Causality; Comorbidity; Contrast Media; Drug-Related Side Effects | 2013 |
Adverse reactions to contrast media: an analysis of spontaneous reports in the database of the pharmacovigilance programme of India.
Topics: Adolescent; Adult; Adverse Drug Reaction Reporting Systems; Child; Child, Preschool; Contrast Media; | 2014 |
Clinical observation of the adverse drug reactions caused by non-ionic iodinated contrast media: results from 109,255 cases who underwent enhanced CT examination in Chongqing, China.
Topics: Adult; China; Contrast Media; Coronary Angiography; Coronary Artery Disease; Dose-Response Relations | 2015 |
Safety and tolerability of iopromide in patients undergoing cardiac catheterization: real-world multicenter experience with 17,513 patients from the TRUST trial.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Age Factors; Aged; Aged, 80 and over; Cardiac Catheteriz | 2015 |
The Incidence, Classification, and Management of Acute Adverse Reactions to the Low-Osmolar Iodinated Contrast Media Isovue and Ultravist in Contrast-Enhanced Computed Tomography Scanning.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Child, Preschool; Contrast Media; Drug-Related Si | 2016 |
Safety and diagnostic image quality of iopromide: results of a large non-interventional observational study of European and Asian patients (IMAGE).
Topics: Adult; Age Distribution; Aged; Angiography; Angiography, Digital Subtraction; Asia; Asian People; Co | 2012 |